Table 1.

Pretreatment characteristics of all eligible patients (n=125)

Age (years)
Median	68
Range	49-81
Race
White	86
African American	32
Asian	2
American Indian/Alaska Native	1
More than one race	2
Unknown or not reported	2
Ethnic Category
Hispanic or Latino	3
Not Hispanic or Latino	99
Unknown or not reported	23
Zubrod performance status
0	121 (97%)
1	4 (3%)
Gleason Score
2-6	13 (10%)
7	90 (72%)
8-10	22 (18%)
PSA
≤ 10	87 (70%)
>10 - ≤ 20	38 (30%)
Median	7.54
Range	0.85-19.30
T-Stage
T1	67 (54%)
T2	47 (38%)
T3	11 (8%)
Hormonal Therapy
No	75 (60%)
Yes	50 (40%)